Lv5
1090 积分 2025-04-05 加入
Immunotherapy of endometrial cancer: a review of recent advances
13天前
已完结
Incorporating Molecular Diagnostics into Treatment Paradigms for Endometrial Cancer
13天前
已完结
Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis
13天前
已完结
Impact of surgery and molecular classification in stage IV endometrial cancer
13天前
已完结
Latest advances in immuno-oncology for endometrial cancer: single-agent and combination regimens
13天前
已完结
Integrating molecular classification into endometrial cancer management
13天前
已完结
Lenvatinib plus pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis
13天前
已完结
Can Endometrial Cytology Identify Patients Who Would Benefit from Immunotherapy?
13天前
已关闭
Association of mismatch repair deficiency in endometrial cancer with 18F-FDG PET/CT and clinicopathological features and their prognostic value
13天前
已完结
Gynecologic cancers in 2025: a year in review
13天前
已关闭
皖公网安备34019202002308
